Appco Pharma LLC recalls Prazosin Hydrochloride Capsules
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- cGMP deviation: detection of Nitrosamine Drug Substance-Related Impurities, N-nitroso-prazosin impurity C (NNP) above acceptable limits.
- Products
-
- Prazosin Hydrochloride Capsules
- Company
- Appco Pharma LLC
- Where it was sold
-
U.S.A. Nationwide
Nationwide
- Units affected
- 58,896 bottles- 100's count
- About this recall
- Prazosin Hydrochloride Capsules, USP, 2mg, 100-count bottle, Rx Only, Manufactured for: Biocon Pharma Inc., Iselin, NJ, Manufactured by: Appco Pharma LLC, Piscataway, NJ, NDC 70377-067-11.